Medical Device Regulation in Sweden
Sweden regulates medical devices under the EU Medical Device Regulation (EU MDR 2017/745), with the Medical Products Agency (Läkemedelsverket) serving as the national competent authority. Sweden has a strong life sciences sector and is home to several medical device manufacturers and innovation hubs. The regulatory framework is fully harmonized with EU requirements.
Sources Tracked by Qalico
Qalico continuously monitors 0 references across guidelines, regulations, and standards for Sweden.
Device Classification
Sweden follows the EU MDR Annex VIII classification rules. Class I includes low-risk devices such as non-powered surgical retractors and corrective spectacle frames. Class IIa includes medium-risk devices such as blood pressure monitors and short-term catheters. Class IIb covers higher-risk devices such as external defibrillators and infusion pumps. Class III includes the highest-risk devices such as total hip replacements and drug-eluting coronary stents.
Official classification guidance →Standards & Key Principles
Applicable Standards
Key Principles
- CE marking under EU MDR 2017/745 is mandatory for devices placed on the Swedish market.
- Economic operators must register with Läkemedelsverket before placing devices on the market.
- Swedish language labeling and instructions for use are required where applicable.
- Clinical investigations require Läkemedelsverket authorization and ethics committee (Etikprövningsmyndigheten) approval.
- Sweden actively participates in EU-wide coordinated market surveillance activities.
Pre-Market Requirements
Manufacturers must complete conformity assessment per EU MDR. Class IIa, IIb, and III devices require Notified Body involvement.
CE marking is mandatory before placing any medical device on the Swedish market.
Manufacturers and authorized representatives must register with Läkemedelsverket and notify the authority of devices made available on the Swedish market.
Comprehensive technical documentation including clinical evaluation, risk management, and design verification data must be maintained per EU MDR Annexes II and III.
Post-Market Requirements
Manufacturers must maintain a PMS system proportionate to device risk, in compliance with EU MDR Chapter VII.
Serious incidents and field safety corrective actions must be reported to Läkemedelsverket in accordance with EU MDR Article 87.
PSURs are required for Class IIa, IIb, and III devices, summarizing PMS data and benefit-risk conclusions.
Läkemedelsverket conducts proactive market surveillance including inspections, testing, and review of device compliance on the Swedish market.
International Recognition & Reliance
As an EU member state, Sweden fully applies the EU MDR and recognizes CE-marked devices certified by any EU-designated Notified Body.